Skip to main content
. 2021 Oct 7;8(10):2070–2082. doi: 10.1002/acn3.51456

Figure 4.

Figure 4

The Kv1.3 blocker PAP‐1 reduces infarction and improves neurological deficit in young and old WT female mice. (A) Infarct area and deficit score in vehicle (n = 11) were compared to PAP‐1 (40 mg/kg; n = 15) treated 16‐week‐old female mice (p = 0.007 for infarct, p = 0.016 for NES). (B) Infarct area and deficit score in vehicle (n = 9) were compared to PAP‐1 (40 mg/kg; n = 9) treated 80‐week‐old female mice (p = 0.032 for infarct, p = 0.003 for NES). Data are shown as whisker plots with data overlay. The boxes show mean ± SEM and the whiskers show confidence intervals.